Asia-Pacific region accounts for 51% of all blindness cases and 56% of cases of visual impairment worldwide due to Diabetic Retinopathy
Novotech Publishes Multi-Specific Monoclonal Antibodies Global Clinical Trial Landscape Report
Singapore - Novotech, the leading Asia Pacific centred biotech CRO has published
Read more